Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA

Research output: PatentResearch

Standard

Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. / Foged, Camilla (Inventor); Franzyk, Henrik (Inventor); Zeng, Xianghui (Inventor); Nielsen, Hanne Mørck (Inventor); Thanki, Kaushik (Inventor).

IPC No.: A61K31/713, A61K47/18, A61K47/34, A61K9/51, A61P25/00, A61P29/00, A61P35/00. Patent No.: WO2017158093-A1. Mar 16, 2017.

Research output: PatentResearch

Harvard

Foged, C, Franzyk, H, Zeng, X, Nielsen, HM & Thanki, K Mar. 16 2017, Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA, Patent No. WO2017158093-A1, IPC No. A61K31/713, A61K47/18, A61K47/34, A61K9/51, A61P25/00, A61P29/00, A61P35/00.

APA

Foged, C., Franzyk, H., Zeng, X., Nielsen, H. M., & Thanki, K. (2017). IPC No. A61K31/713, A61K47/18, A61K47/34, A61K9/51, A61P25/00, A61P29/00, A61P35/00. Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. (Patent No. WO2017158093-A1).

Vancouver

Foged C, Franzyk H, Zeng X, Nielsen HM, Thanki K, inventors. Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. A61K31/713, A61K47/18, A61K47/34, A61K9/51, A61P25/00, A61P29/00, A61P35/00. 2017 Sep 21.

Author

Foged, Camilla (Inventor) ; Franzyk, Henrik (Inventor) ; Zeng, Xianghui (Inventor) ; Nielsen, Hanne Mørck (Inventor) ; Thanki, Kaushik (Inventor). / Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA. IPC No.: A61K31/713, A61K47/18, A61K47/34, A61K9/51, A61P25/00, A61P29/00, A61P35/00. Patent No.: WO2017158093-A1. Mar 16, 2017.

Bibtex

@misc{11f632b0756f452cae5ffe0a0a05570b,
title = "Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA",
abstract = "The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.",
author = "Camilla Foged and Henrik Franzyk and Xianghui Zeng and Nielsen, {Hanne M{\o}rck} and Kaushik Thanki",
year = "2017",
month = "9",
day = "21",
language = "English",
type = "Patent",
note = "WO2017158093-A1; A61K31/713,A61K47/18,A61K47/34,A61K9/51,A61P25/00,A61P29/00,A61P35/00",

}

RIS

TY - PAT

T1 - Nanoparticle compositions comprising PLGA derivatives and a lipid for delivery of drugs, in particular nucleic acids, especially siRNA

AU - Foged, Camilla

AU - Franzyk, Henrik

AU - Zeng, Xianghui

AU - Nielsen, Hanne Mørck

AU - Thanki, Kaushik

PY - 2017/9/21

Y1 - 2017/9/21

N2 - The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.

AB - The present invention relates to a nanoparticle compn. comprising PLGA derivs. and a lipid. The compn. is suitable for medical use. Particularly, the present invention relates to a delivery system for delivery of drugs, in particular nucleic acids, with enhanced efficacy and reduced adverse effects, such as reduced toxicity and immunogenicity, on healthy tissue. More precisely, the present invention relates to a delivery system comprising hybrid nanoparticles comprising PLGA and lipidoids for the delivery of siRNA.

M3 - Patent

M1 - WO2017158093-A1

Y2 - 2017/03/16

ER -

ID: 199168708